CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation Lifestyle Modifications for Preventing and Treating Heart Failure Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced Association of Cardiovascular Disease With Respiratory Disease Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure Dapagliflozin for treating chronic heart failure with reduced ejection fraction Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Recommandation Statement2018 May 15;137(20):e578-e622.

JOURNAL:Circulation. Article Link

Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association

Konstam MA, Kiernan MS, American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia. Keywords: AHA Scientific Statements; causality; disease management; heart failure; ventricular dysfunction, right

FULL TEXT PDF